An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes

Authors

Farzad Asadi, Washington University School of Medicine in St. Louis
Subhadra C. Gunawardana, Washington University School of Medicine in St. Louis
Roland E. Dolle, Washington University School of Medicine in St. Louis
David W. Piston, Washington University School of Medicine in St. Louis

Journal

JCI Insight

Publication Date

1-23-2024

Volume

9

Issue

2

First Page

e172626

Document Type

Open Access Publication

DOI

10.1172/jci.insight.172626

Rights and Permissions

Asadi F, Gunawardana SC, Dolle RE, Piston DW. An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes. JCI Insight. 2024 Jan 23;9(2):e172626. doi: 10.1172/jci.insight.172626. © 2024, Asadi et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Recommended Citation

Asadi, Farzad; Gunawardana, Subhadra C.; Dolle, Roland E.; and Piston, David W., "An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes." JCI Insight. 9, 2. e172626 (2024).
https://digitalcommons.wustl.edu/oa_4/3101

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.